Drugs

As use becomes more widespread, understanding cannabinoid interactions with medications is essential for pharmacists and other healthcare providers.

A Health Canada safety review concludes that there is a possible link between statin (HMG-CoA reductase inhibitor) use and the risk of myasthenia gravis.

At Neighbourhood Pharmacies of Canada’s annual Specialty Pharmacy Summit, the message was clear. Community pharmacies should no longer feel excluded from the specialty pharmacy arena.

Pharmacists can play an important role in screening patients for hypothyroidism.

From our December drug news roundup, check out this key Health Canada advisory relating to risk of SIADH and hyponatremia.

As pat of our December drug news roundup, here are six new indications for existing drugs.

Get the info you need on this new product, part of our drug news roundup for December.

Get the info you need on this new product, part of our drug news roundup for December.